Sacklers Took in Nearly $13 Billion From Purdue Pharma, States Say

Sacklers Took in Nearly $13 Billion From Purdue Pharma, States Say
A bottle of prescription painkiller OxyContin, 40mg pills, made by Purdue Pharma L.D. at a local pharmacy, in Provo, Utah on April 25, 2017. George Frey/Reuters
Bowen Xiao
Updated:

Pharmaceutical company Purdue Pharma, which recently filed for bankruptcy after thousands of lawsuits alleged that the company helped fuel an opioid epidemic in the United States, moved up to $13 billion in profits to the company’s controlling family, the Sacklers, according to an unspecified number of U.S. states.

The states said the Sacklers received the money from Purdue during an unspecified time frame, according to court documents and portions of a deposition filed in the drugmaker’s bankruptcy proceedings on Oct. 3 and 4. The company ultimately transferred $12 billion or $13 billion to the family, a company adviser testified in a deposition that was revealed in recent court filings.
Bowen Xiao
Bowen Xiao
Reporter
Bowen Xiao was a New York-based reporter at The Epoch Times. He covers national security, human trafficking and U.S. politics.
twitter
Related Topics